Data / Drug companies / Carnegie Pharmaceuticals LLC
Carnegie Pharmaceuticals LLC: 17 products in the FDA NDC directory, labeler code 80005
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Carnegie Pharmaceuticals LLC (labeler code 80005) lists 17 products in the FDA National Drug Code Directory, covering 10 finished drugs by generic name. By type: 17 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on June 30, 2026.
The request: Watch Carnegie Pharmaceuticals LLC (FDA labeler code 80005): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 80005
- Products in commercial distribution
- 17
- Packages
- 27
- Finished drugs by generic name
- 10
- Prescription products
- 17
- Over the counter products
- 0
- Flagged as original packager
- 17 of 17 products that carry the flag
- Started marketing in the last 12 months
- 7
- Earliest marketing start
- March 15, 2021
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 17 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 17 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Lomustine | 3 | 4 |
| Aminocaproic acid | 3 | 23 |
| Etravirine | 2 | 7 |
| Rasagiline mesylate | 2 | 6 |
| Primidone | 2 | 23 |
| Famotidine | 1 | 138 |
| Balsalazide disodium | 1 | 9 |
| Clindamycin phosphate topical | 1 | 2 |
| Vigabatrin | 1 | 18 |
| Letrozole | 1 | 17 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 8 | 47.1% |
| Capsule | 4 | 23.5% |
| Solution | 2 | 11.8% |
| Tablet, film coated | 2 | 11.8% |
| Powder, for suspension | 1 | 5.9% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Letrozole | 80005-139 | Tablet, film coated | Generic drugs (ANDA) | June 30, 2026 |
| Vigabatrin | 80005-167 | Tablet, film coated | Generic drugs (ANDA) | February 18, 2026 |
| Rasagiline | 80005-142 | Tablet | Generic drugs (ANDA) | January 15, 2026 |
| Rasagiline | 80005-141 | Tablet | Generic drugs (ANDA) | January 15, 2026 |
| Lomustine | 80005-116 | Capsule | Generic drugs (ANDA) | November 10, 2025 |
| Lomustine | 80005-115 | Capsule | Generic drugs (ANDA) | November 10, 2025 |
| Lomustine | 80005-114 | Capsule | Generic drugs (ANDA) | November 10, 2025 |
| Balsalazide disodium | 80005-126 | Capsule | Generic drugs (ANDA) | June 30, 2025 |
| Clindamycin Phosphate | 80005-131 | Solution | Generic drugs (ANDA) | June 16, 2025 |
| Primidone | 80005-118 | Tablet | Generic drugs (ANDA) | May 1, 2024 |
| Primidone | 80005-117 | Tablet | Generic drugs (ANDA) | May 1, 2024 |
| Famotidine | 80005-119 | Powder, for suspension | Generic drugs (ANDA) | August 10, 2023 |
| Etravirine | 80005-113 | Tablet | Generic drugs (ANDA) | June 7, 2022 |
| Etravirine | 80005-112 | Tablet | Generic drugs (ANDA) | June 7, 2022 |
| Aminocaproic acid | 80005-130 | Solution | Generic drugs (ANDA) | March 18, 2021 |
| Aminocaproic acid | 80005-129 | Tablet | Generic drugs (ANDA) | March 15, 2021 |
| Aminocaproic acid | 80005-128 | Tablet | Generic drugs (ANDA) | March 15, 2021 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.